Antitumor effects of low-dose metronomic cyclophosphamide combined with Herceptin in orthotopic erbB2-overexpressing mammary tumors.

被引：0
|
作者：
Du Manoir, JM [1 ]
Viloria-Petit, A [1 ]
Man, S [1 ]
Mossoba, M [1 ]
Medin, JA [1 ]
Kerbel, RS [1 ]
机构：
[1] Univ Toronto, Dept Med Biophys, Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON, Canada
来源：
CLINICAL CANCER RESEARCH | 2003年 / 9卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6149S / 6149S
页数：1
相关论文
共 50 条
  • [41] A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors
    Hijikata, Yasuki
    Okazaki, Toshihiko
    Tanaka, Yoshihiro
    Murahashi, Mutsunori
    Yamada, Yuichi
    Yamada, Kazunari
    Takahashi, Atsushi
    Inoue, Hiroyuki
    Kishimoto, Junji
    Nakanishi, Yoichi
    Oda, Yoshinao
    Nakamura, Yusuke
    Tani, Kenzaburo
    PLOS ONE, 2018, 13 (01):
  • [42] A phase I clinical trial of RNF43 peptide-specific immune cell therapy combined with low-dose cyclophosphamide for patients with advanced solid tumors
    Hijikata, Yasuki
    Okazaki, Toshihiko
    Inoue, Hiroyuki
    Tanaka, Yoshihiro
    Tani, Kenzaburo
    Kobayashi, Shinichi
    Yoshida, Koji
    CANCER RESEARCH, 2014, 74 (19)
  • [43] A multicenter Phase II study of Epirubicin (E) with low-dose Herceptin (LD-H) as a first line treatment in HER-2 overexpressing metastatic breast cancer (MBC): Preliminary results
    De Tursi, M.
    Carella, C.
    Ricevuto, E.
    Marchetti, P.
    Gennari, A.
    Orlandini, C.
    Frassoldati, A.
    Conte, P.
    Iacobelli, S.
    EJC SUPPLEMENTS, 2005, 3 (02): : 116 - 116
  • [44] Low-dose X-ray radiodynamic therapy solely based on gold nanoclusters for efficient treatment of deep hypoxic solid tumors combined with enhanced antitumor immune response
    Zhu, Shengcang
    Yan, Feihong
    Yang, Lulu
    Li, Bingyi
    Xue, Ruxian
    Yu, Wenwen
    Wang, Yu
    Huang, Lu
    Wang, Lijun
    Han, Rongcheng
    Jiang, Yuqiang
    THERANOSTICS, 2023, 13 (03): : 1042 - 1058
  • [45] Antitumor effects of heparin-polyethyleneimine nanogels delivering claudin-3-targeted short hairpin RNA combined with low-dose cisplatin on ovarian cancer
    Liu, Lili
    Gou, Maling
    Yi, Tao
    Bai, Yu
    Wei, Yuquan
    Zhao, Xia
    ONCOLOGY REPORTS, 2014, 31 (04) : 1623 - 1628
  • [46] Randomized phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced soft-tissue sarcoma
    Maud Toulmonde
    Sophie Cousin
    Michèle Kind
    Jean-Philippe Guegan
    Alban Bessede
    Francois Le Loarer
    Raul Perret
    Coralie Cantarel
    Carine Bellera
    Antoine Italiano
    Journal of Hematology & Oncology, 15
  • [47] Randomized phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced soft-tissue sarcoma
    Toulmonde, Maud
    Cousin, Sophie
    Kind, Michele
    Guegan, Jean-Philippe
    Bessede, Alban
    Le Loarer, Francois
    Perret, Raul
    Cantarel, Coralie
    Bellera, Carine
    Italiano, Antoine
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [48] INDUCTION OF ANTITUMOR IMMUNITY AND TREATMENT OF PREESTABLISHED TUMOR BY INTERLEUKIN-6-GENE TRANSFECTED MELANOMA-CELLS COMBINED WITH LOW-DOSE INTERLEUKIN-2
    CAO, XT
    ZHANG, WP
    GU, S
    YU, YZ
    TAO, Q
    YE, TX
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1995, 121 (12) : 721 - 728
  • [49] Efficacy and Safety of Nivolumab Combined with Daratumumab with or without Low-Dose Cyclophosphamide in Relapsed/Refractory Multiple Myeloma; Interim Analysis of the Phase 2 Nivo-Dara Study
    Verkleij, Christie P. M.
    Minnema, Monique C.
    de Weerdt, Okke
    Bosman, Patricia W. C.
    Frerichs, Kristine A.
    Croockewit, Alexandra J.
    Klein, Saskia K.
    Bos, Gerard
    Mutis, Tuna
    Plattel, Wouter J.
    van der Spek, Ellen
    Broyl, Annemiek
    Sonneveld, Pieter
    Zweegman, Sonja
    Levin, Mark-David
    Van de Donk, Niels W. C. J.
    BLOOD, 2019, 134
  • [50] Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: Modulation of interleukin-2-induced antitumor immunity by blocking the opioid system
    Lissoni, P
    Malugani, F
    Malysheva, O
    Kozlov, V
    Laudon, M
    Conti, A
    Maestroni, G
    NEUROENDOCRINOLOGY LETTERS, 2002, 23 (04) : 341 - 344
12345